BRIEF

← Today's Brief
Economy  ·  26 days ago

India slashes cancer drug prices drastically

— The National Pharmaceutical Pricing Authority in India has reduced the maximum retail prices of cancer medications by up to 93%, including a ₹72,921 drop for Thiotepa. This move aims to enhance affordability of critical treatments.

First reported by livemint.com  ·  developing for 26 days  ·  livemint.com
Why it matters

These reductions could save lives by making life-saving treatment more accessible.

Context

Drug pricing reforms are essential for expanding treatment access in India.